Apexigen, a biopharmaceutical company, has announced the filing of investigational new drug (IND) application for APX001, also known as SSS07, by its partner 3SBio [SSRX] of Shenyang, China. With the IND approval, APX001/SSS07 will be ...
Tags: IND approval, clinical trials, autoimmune diseases, inflammatory diseases
AstraZeneca, a biopharmaceutical company, has completed the purchase of a US-based biotechnology company, Ardea Biosciences. Upon completion of the merger, approved by Ardea's stockholders, each outstanding share of Ardea common stock has ...
Tags: purchase, AstraZeneca, Ardea Biosciences, biopharmaceutical
Pain Therapeutics, a biopharmaceutical company, has received four US patents covering Remoxy (oxycodone) extended-release capsules CII. The issued patents are licensed exclusively to Pain Therapeutics in the US and international ...
Tags: Patent, extended-release capsule, pharmaceutical product